PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 8-K

What Happened
Pacific Biosciences of California, Inc. (PACB) filed an 8-K disclosing that director Christopher M. Smith notified the company of his resignation from the board, effective immediately on July 8, 2026. The 8-K was signed by General Counsel Brett Atkins on July 9, 2026.

Key Details

• Resignation date and effective date: July 8, 2026 (effective immediately).
• Filing: Form 8-K under Item 5.02 (Departure of Directors or Certain Officers), signed July 9, 2026.
• Company statement: The company is not aware of any disagreement between Mr. Smith and the company regarding its operations, policies or practices that led to the resignation.
• No replacement or committee changes were disclosed in the filing.

Why It Matters
A board resignation affects corporate governance and may create a vacancy the company will need to fill; investors should watch for future disclosures about a replacement or any committee reassignments. The filing’s note that there were no disagreements suggests the departure was not tied to a public dispute over company operations or policies.